PbN IO: The D Contemplation

 
 O                  2.4              I    ALTHCAREEN       MENT s 
                  5                  D     WITHCONFI       RSUS p 
                            8.2      R    EXAMINATIO   8.3 NATI o 
                         6.6         N    ONRISKCATE       S SE c 
        -                      6.5   S    LPROTECTIO       NGDE c 
                  5                  D     WITHCONFI       RSUS p 
           3.2                 3.3   G    TICPROCEDU     3 .4SU r 
                                    5.3   RGICALPATH        5.4 t 
           3.2                 3.3   G    TICPROCEDU     3 .4SU r 
                         6.6         N    ONRISKCATE       S SE c 
                                4    G    NTOFHEALTH  /    ISK/ i 
                          5.1        T    EALTHCAREL       TORY   
                                  6  C    AMINATIONP       URES   
       8.5                      8.6  H    TIONS 8.7B       NATI o 
 ;                       -           E                            
                            1        R     PANTS ANN   2   STOF p 
  .1                     4.2    -    S    MANAGEMENT       ION5 l 
                          5.1        T    EALTHCAREL       TORY   
                                4    G    NTOFHEALTH  /    ISK/ i 
         3            3.1            T    THEHOMEAND       HCAR e 
           3.2                 3.3   G    TICPROCEDU     3 .4SU r 
      7                      8       A    8.1PRECAUT       ORHA n 
                          5.1        T    EALTHCAREL       TORY   
       3.7                           I  4 OCCUPATION       URY  4 
  .1                     4.2    -    S    MANAGEMENT       ION5 l 
                            8.2      R    EXAMINATIO   8.3 NATI o 
  3                              6.4 E    TAMINATION       TESA n 
 G                                   E    PHALOPATHI    2. 3IAT r 
                         6.6         N    ONRISKCATE       S SE c 
                                     S 8. 4UNDERTAKE       EMBA l 
                                  6  C    AMINATIONP       URES   
  3                              6.4 E    TAMINATION       TESA n 
                                  6  C    AMINATIONP       URES   
         3            3.1            T    THEHOMEAND       HCAR e 
  .1                     4.2    -    S    MANAGEMENT       ION5 l 
                                     S 8. 4UNDERTAKE       EMBA l 
                    3                E    DSFORTRANS       BLES p 
  6.1                      6.2       M    TIONOFINST       TS 6 . 
                            1        R     PANTS ANN   2   STOF p 
                  5                  D     WITHCONFI       RSUS p 
 O                  2.4              I    ALTHCAREEN       MENT s 
  .1                     4.2    -    S    MANAGEMENT       ION5 l 
                         6.6         N    ONRISKCATE       S SE c 
                                  6  C    AMINATIONP       URES   
  .1                     4.2    -    S    MANAGEMENT       ION5 l 
 ;                       -           E                            
 O                  2.4              I    ALTHCAREEN       MENT s 
  3                              6.4 E    TAMINATION       TESA n 
  3                              6.4 E    TAMINATION       TESA n 
         3            3.1            T    THEHOMEAND       HCAR e 
 I                                   U    SANDINANIM     2 .2DI a 
 S      1                    2       C    IDERATIONS  2.1  RANS m 
  .1                     4.2    -    S    MANAGEMENT       ION5 l 
 O                  2.4              I    ALTHCAREEN       MENT s 
  6.1                      6.2       M    TIONOFINST       TS 6 . 
                                     S 8. 4UNDERTAKE       EMBA l 
  6.1                      6.2       M    TIONOFINST       TS 6 . 
                  5                  D     WITHCONFI       RSUS p 
                         6.6         N    ONRISKCATE       S SE c 
 S      1                    2       C    IDERATIONS  2.1  RANS m 
                  3.5                A    STRUMENTS  3.6   AEST h 
                                  6  C    AMINATIONP       URES   
 G                                   E    PHALOPATHI    2. 3IAT r 
  6.1                      6.2       M    TIONOFINST       TS 6 . 
                                     S 8. 4UNDERTAKE       EMBA l 
         3            3.1            T    THEHOMEAND       HCAR e 
 O                  2.4              I    ALTHCAREEN       MENT s 
 S      1                    2       C    IDERATIONS  2.1  RANS m 
 I                                   U    SANDINANIM     2 .2DI a 
                                    5.3   RGICALPATH        5.4 t 
                                     S 8. 4UNDERTAKE       EMBA l 
           3.2                 3.3   G    TICPROCEDU     3 .4SU r 
 S      1                    2       C    IDERATIONS  2.1  RANS m 
                                     S 8. 4UNDERTAKE       EMBA l 
 G                                   E    PHALOPATHI    2. 3IAT r 
        -                      6.5   S    LPROTECTIO       NGDE c 
                                     S 8. 4UNDERTAKE       EMBA l 
                  3.5                A    STRUMENTS  3.6   AEST h 
                  5                  D     WITHCONFI       RSUS p 
           3.2                 3.3   G    TICPROCEDU     3 .4SU r 
                          5.1        T    EALTHCAREL       TORY   
                                     S 8. 4UNDERTAKE       EMBA l 
        -                      6.5   S    LPROTECTIO       NGDE c 
  .1                     4.2    -    S    MANAGEMENT       ION5 l 
                         6.6         N    ONRISKCATE       S SE c 
      7                      8       A    8.1PRECAUT       ORHA n 
 G                                   E    PHALOPATHI    2. 3IAT r 
 G                                   E    PHALOPATHI    2. 3IAT r 
 ;                       -           E                            
                          5.1        T    EALTHCAREL       TORY   
 ;                       -           E                            
 G                                   E    PHALOPATHI    2. 3IAT r 
 I                                   U    SANDINANIM     2 .2DI a 
                                     S 8. 4UNDERTAKE       EMBA l 
 S      1                    2       C    IDERATIONS  2.1  RANS m 
  6.1                      6.2       M    TIONOFINST       TS 6 . 
         3            3.1            T    THEHOMEAND       HCAR e 
        -                      6.5   S    LPROTECTIO       NGDE c 
         3            3.1            T    THEHOMEAND       HCAR e 
 G                                   E    PHALOPATHI    2. 3IAT r

 
H1,    5},    {      { Name'creutzfeldt- JAKOBDISEA seand RELA t
9',      '27',      '1994-2004', languag E'ENG', PU bstat USPP u
     ,                ', qual{ { subh'tr ANSMISSION '}, {  MPT r
   '            '}}}, { term'human'}, {  TERM'IATRO genic DISE a
9672}},     { {     '  Imals'}, { term'c ATTLE'}, {  mptr UE,  t
  { {             ,    E'prions'}}, pmid 9869672, P ub-ty PE{  '
     ,                ', qual{ { subh'tr ANSMISSION '}, {  MPT r
 {          ,    '   : Engljmed.1999may2  ;340(21): 1687- 8;AU t
     ,                ', qual{ { subh'tr ANSMISSION '}, {  MPT r
B    ,        { {      Atusmedline, date  STD{ YEAR 2001,  MON t
 {     '         '}, { Subh'genetics'},  { SUBH'CLA ssifi CATI o
E                      Rm encephalopathi ES.'}, AUT hors{  NAM e
 {          ,    '   : Engljmed.1999may2  ;340(21): 1687- 8;AU t
   '            '}}}, { term'human'}, {  TERM'IATRO genic DISE a
   .1999   27;340(21):1688-9.pmid:103486  9'}, { TY peoth ER,  s
9',      '27',      '1994-2004', languag E'ENG', PU bstat USPP u
 62'}, {          ,    'sb:aim'}, { type OTHER, STR 'sb:i M'},  
  '}}}, {       ,     'Diseaseoutbreaks' }, { TERM' encep HALO p
H3,    28,     10,     Te1}}, { pubstatu SPUBMED, D ate s TD{  y
   { {     '           '}}}, { term'risk FACTORS'}} , sub STAN c
H1,    5},    {      { Name'creutzfeldt- JAKOBDISEA seand RELA t
S   { '         ', '   Bscjjr'}, affil s TR'DEPARTM entof NEUR o
         1689.     :10348687'}, { typeot HER, STR'C in:ne NGLJ m
E  '           -       Ndrome', qual{ {  SUBH'TRANS missi ON'} ,
L   ,                  Sityschoolof medi CINE,BALTI more, MD21 2
L   ,                  Sityschoolof medi CINE,BALTI more, MD21 2
H1,    5},    {      { Name'creutzfeldt- JAKOBDISEA seand RELA t
   ,     '            '}}}, { term'great BRITAIN',  qual{  { S u
;004'}},              }}                                        
   '}, {     '         Ases', qual{ { su BH'VETERIN ary'} , {  s
B    ,        { {      Atusmedline, date  STD{ YEAR 2001,  MON t
E                      Rm encephalopathi ES.'}, AUT hors{  NAM e
9',      '27',      '1994-2004', languag E'ENG', PU bstat USPP u
  { {             ,    E'prions'}}, pmid 9869672, P ub-ty PE{  '
  '}}}, {       ,     'Diseaseoutbreaks' }, { TERM' encep HALO p
   { {     '           '}}}, { term'risk FACTORS'}} , sub STAN c
 {     '         '}, { Subh'genetics'},  { SUBH'CLA ssifi CATI o
;004'}},              }}                                        
   { {     '           '}}}, { term'risk FACTORS'}} , sub STAN c
 {          ,    '   : Engljmed.1999may2  ;340(21): 1687- 8;AU t
E  1998,      12,    31, hour3, minute1} }}}}, IDS{  pubm ED98 6
   { {     '           '}}}, { term'risk FACTORS'}} , sub STAN c
B    ,        { {      Atusmedline, date  STD{ YEAR 2001,  MON t
S   { '         ', '   Bscjjr'}, affil s TR'DEPARTM entof NEUR o
   '   :         .1999 Ay27;340(21):1688 ;AUTHORREP ly168 9. P m
         1689.     :10348687'}, { typeot HER, STR'C in:ne NGLJ m
   .1999   27;340(21):1688-9.pmid:103486  9'}, { TY peoth ER,  s
   .1999   27;340(21):1688-9.pmid:103486  9'}, { TY peoth ER,  s
   '   :         .1999 Ay27;340(21):1688 ;AUTHORREP ly168 9. P m
   :10348688'}, {      Ther, str'so:1998 DEC31;339( 27):1 994- 2
H3,    28,     10,     Te1}}, { pubstatu SPUBMED, D ate s TD{  y
H1,    5},    {      { Name'creutzfeldt- JAKOBDISEA seand RELA t
         ,    '  :     Dstates'}, { type OTHER, STR 'jid: 0255 5
   { {     '           '}}}, { term'risk FACTORS'}} , sub STAN c
-4793'},    {         { year1998, month1 2, DAY31},  volu ME'3 3
P     -     ::={     9869672, medent{ em  STD{ YEAR 1999,  MON t
H3,    28,     10,     Te1}}, { pubstatu SPUBMED, D ate s TD{  y
E  1998,      12,    31, hour3, minute1} }}}}, IDS{  pubm ED98 6
    '        '}, {     'epidemiology'}}} , { TERM'P rions ', Q u
         ,    '  :     Dstates'}, { type OTHER, STR 'jid: 0255 5
E                      Rm encephalopathi ES.'}, AUT hors{  NAM e
    '        '}, {     'epidemiology'}}} , { TERM'P rions ', Q u

 
Med.1999may27;340(21):1687-8;authorreply 1689.PMID:  1034 8687  
Gljmed.1999May27;340(21):1688;authorrepl Y1689.PMID :1034 8688  
Mh-animals Mh-cattle mh-*creutzfeldt-jak OBSYNDROME /     SIFI c
Pmid-9869672 own-nlm stat-completed da-1 9990105 DC   -19 9901 0
Pmid-9869672 own-nlm stat-completed da-1 9990105 DC   -19 9901 0
 /drugeffecTs mh-riskfactors rf-82 edat- 1998/12/31 03:01  MHD a
NsuniversitYschoolofmedicine, baltimore, MD21287,US  .    U-JO h
Nson,rt au-Johnsonrt fau-gibbs,cjjr au-g IBBSCJJR L  -     PT- j
Tzfeldt-jakObdiseaseandrelatedtransmissi BLESPONGIF       NCEP h
 mh-priondiSeases/epidemiology/etiology/ VETERINARY    -  RION s
OurnalarticLe pt-review pt-review,tutori AL PL-UNIT       TES  t
::1994-2004.                                                    
Alopathies. pg-1994-2004 ad-departmentof NEUROLOGY,       HOPK i
Med.1999may27;340(21):1687-8;authorreply 1689.PMID:  1034 8687  
5 lr-20031114 is-0028-4793 vi-339 ip-27  DP-1998DEC 31    -CRE u
Med.1999may27;340(21):1687-8;authorreply 1689.PMID:  1034 8687  
::1994-2004.                                                    
5 lr-20031114 is-0028-4793 vi-339 ip-27  DP-1998DEC 31    -CRE u
Pmid-9869672 own-nlm stat-completed da-1 9990105 DC   -19 9901 0
A-nengljmed jid-0255562 rn-0(prions) sb- AIM SB-IM     -  ENGL j
H-encephaloPathy,bovinespongiform/*epide MIOLOGY/TR       SSIO n
Tzfeldt-jakObdiseaseandrelatedtransmissi BLESPONGIF       NCEP h
 -2001/03/2810:01 pst-ppublish so-nenglj MED1998DEC 31;33 9(27 )
Alopathies. pg-1994-2004 ad-departmentof NEUROLOGY,       HOPK i
Tzfeldt-jakObdiseaseandrelatedtransmissi BLESPONGIF       NCEP h
5 lr-20031114 is-0028-4793 vi-339 ip-27  DP-1998DEC 31    -CRE u
5 lr-20031114 is-0028-4793 vi-339 ip-27  DP-1998DEC 31    -CRE u
H-encephaloPathy,bovinespongiform/*epide MIOLOGY/TR       SSIO n
Cin-nengljmEd.1999may27;340(21):1688-9.p MID:103486 89    N-NE n
NsuniversitYschoolofmedicine, baltimore, MD21287,US  .    U-JO h
Tzfeldt-jakObdiseaseandrelatedtransmissi BLESPONGIF       NCEP h
 /drugeffecTs mh-riskfactors rf-82 edat- 1998/12/31 03:01  MHD a
::1994-2004.                                                    
Tzfeldt-jakObdiseaseandrelatedtransmissi BLESPONGIF       NCEP h
Tzfeldt-jakObdiseaseandrelatedtransmissi BLESPONGIF       NCEP h
Nson,rt au-Johnsonrt fau-gibbs,cjjr au-g IBBSCJJR L  -     PT- j
H-encephaloPathy,bovinespongiform/*epide MIOLOGY/TR       SSIO n
::1994-2004.

 
;                       -           E                           
;                       6.6         N    E c                    
;     3.7                           I  4   4                    
;                  2.4              I    T s                    
;                       -           E                           
;                5                  D    S p                    
;     3.7                           I  4   4                    
;.1                     4.2    -    S    5 l                    
;         3.2                 3.3   G    U r                    
I                8600             ,      SDA,MD2089 4           
E            .          ,         .      RTMENTOFNE U     GY,J o
I                8600             ,      SDA,MD2089 4           
H                                   ,    TIMORE,MD2 1287, USA.  
   ]                                     MATION U.S .     ONAL l
   ]                                     MATION U.S .     ONAL l
H                                   ,    TIMORE,MD2 1287, USA.  
A                                 /      MIOLOGY PR I     SEAS e
-             */                    -    OBSYNDROME */    HOLO g
P               :              ,          MESHTERMS :     MALS  
Y            -             */            N DISEASEO U     AKS*  
S/                      /                NS/DRUGEFF E     RISK f
C                 -             */       FICATION C R     FELD t
E             ,                /         LOGY* ENCE P     PATH y
 
 
 
 
 
 
 
S/                      /                NS/DRUGEFF E     RISK f
E            .          ,         .      RTMENTOFNE U     GY,J o
C          -                             ISSIBLESPO N     RMEN c
E            .          ,         .      RTMENTOFNE U     GY,J o
Y            -             */            N DISEASEO U     AKS*  
H                                   ,    TIMORE,MD2 1287, USA.  
P               :              ,          MESHTERMS :     MALS  
I                8600             ,      SDA,MD2089 4           
E            .          ,         .      RTMENTOFNE U     GY,J o
A                :            :9869672[  UBMED-INDE X     RMED l
A                                 /      MIOLOGY PR I     SEAS e
E            .          ,         .      RTMENTOFNE U     GY,J o
C                 -             */       FICATION C R     FELD t
H                                   ,    TIMORE,MD2 1287, USA.  
;                  2.4              I    T s                    
;                                   U    I a                    
;     8.5                      8.6  H    I o                    
;3                              6.4 E    A n                    
;      -                      6.5   S    E c                    
;     8.5                      8.6  H    I o                    
;     3.7                           I  4   4                    
;                                  5.3   4 t                    
;     8.5                      8.6  H    I o

Poem by Nari IO:

 
;    7                      8       A    A n                    
;      -                      6.5   S    E c                    
;                3.5                A    T h                    
;6.1                      6.2       M    6 .                    
;     8.5                      8.6  H    I o                    
;3                              6.4 E    A n                    
;.1                     4.2    -    S    5 l                    
;6.1                      6.2       M    6 .                    
;                       -           E                           
S/                      /                NS/DRUGEFF E     RISK f
E             ,                /         LOGY* ENCE P     PATH y
,                /                       AIN/EPIDEM I     Y HU m
C          -                             ISSIBLESPO N     RMEN c
C                 -             */       FICATION C R     FELD t
C          -                             ISSIBLESPO N     RMEN c
E             ,                /         LOGY* ENCE P     PATH y
E            .          ,         .      RTMENTOFNE U     GY,J o
,                /                       AIN/EPIDEM I     Y HU m
E            .          ,         .      RTMENTOFNE U     GY,J o
P               :              ,          MESHTERMS :     MALS  
S/                      /                NS/DRUGEFF E     RISK f
C          -                             ISSIBLESPO N     RMEN c
Y            -             */            N DISEASEO U     AKS*  
 
 
 
 
 
 
 
 
 
C          -                             ISSIBLESPO N     RMEN c
,                /                       AIN/EPIDEM I     Y HU m
I                8600             ,      SDA,MD2089 4           
,                /                       AIN/EPIDEM I     Y HU m
-             */                    -    OBSYNDROME */    HOLO g
P               :              ,          MESHTERMS :     MALS  
E             ,                /         LOGY* ENCE P     PATH y
C          -                             ISSIBLESPO N     RMEN c
E             ,                /         LOGY* ENCE P     PATH y
C                 -             */       FICATION C R     FELD t
P               :              ,          MESHTERMS :     MALS  
S/                      /                NS/DRUGEFF E     RISK f
E             ,                /         LOGY* ENCE P     PATH y
-             */                    -    OBSYNDROME */    HOLO g
;                                  5.3   4 t                    
;      -                      6.5   S    E c                    
;                       -           E                           
;                  2.4              I    T s                    
;      1                    2       C    S m                    
;                                  5.3   4 t                    
;                        5.1        T    Y                      
;      -                      6.5   S    E c                    
;                                  5.3   4 t